Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) News
Filter AVDL News Items
AVDL News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest AVDL News From Around the Web
Below are the latest news stories about AVADEL PHARMACEUTICALS PLC that investors may wish to consider to help them evaluate AVDL as an investment opportunity.
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call TranscriptAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript November 8, 2023 Avadel Pharmaceuticals plc misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.35. Operator: Greetings, and welcome to the Avadel Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions]. It is now my pleasure to introduce Austin Murtagh with Stern Investor Relations. […] |
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results-- $7.0 million in third quarter LUMRYZ™ net revenue from U.S. commercial launch -- -- Generated robust demand for LUMRYZ with greater than 1,000 patients enrolled in RYZUPTM and more than 400 patients initiating therapy as of September 30 -- -- LUMRYZ to be added to preferred position for CVS commercial formularies effective January 1, 2024 -- -- Submitted sNDA for LUMRYZ in pediatric narcolepsy population on November 7th -- -- Management to host a conference call today at 8:30 a.m. ET -- DUBLI |
Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesDUBLIN, Ireland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference: Fireside chat on Tuesday, November 14 at 5:00 p.m. GMT / 12:00 p.m. ET.Piper Sandler 35th Annual Healthcare Conference: Fireside chat on Wednesday, November 29 at 11:30 a.m. ET |
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8DUBLIN, Ireland, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 8, 2023, to provide a corporate update and discuss the Company's financial results for the third quarter ended September 30, 2023. A live audio webcast of the call be accessed by visiting the investor relations secti |
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023– 17 abstracts accepted, including new and encore data emphasizing clinical benefit and patient preference for a once-at-bedtime narcolepsy treatment option – – Company to host symposium on October 24 with leading KOLs discussing evolution of the narcolepsy treatment landscape – DUBLIN, Ireland, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced new and encore data supporting the clinical pr |
Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro SummitDUBLIN, Ireland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies Biotech CNS/Neuro Summit on Thursday, October 12 at 9:00 a.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days |
Avadel Pharmaceuticals PLC (AVDL): Is It Really Priced Right? An In-depth ExplorationUnraveling the True Worth of Avadel Pharmaceuticals PLC Amidst Market Fluctuations |
Avadel Pharmaceuticals plc's (NASDAQ:AVDL) institutional investors lost 7.6% last week but have benefitted from longer-term gainsKey Insights Significantly high institutional ownership implies Avadel Pharmaceuticals' stock price is sensitive to... |
12 Best High Risk High Reward Stocks To Buy NowIn this piece, we will take a look at the 12 best high risk high reward stocks to buy now. If you want to skip our background on investing, then head on over to 5 Best High Risk High Reward Stocks To Buy Now. Investing is a risky endeavor, as is anything that involves the […] |
Geoffrey Glass Bought 13% More Shares In Avadel PharmaceuticalsPotential Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) shareholders may wish to note that the Independent Non-Executive... |